chereb19
1 minute ago
You keep repeating the same talking points, but they’re built on conjecture, not facts. Saying “it’s all irrelevant until FDA sees results” is an easy dodge to dismiss everything the company has done—regulatory approvals, clinical logistics, protocol design with FDA input, and collaboration with May